BRAIN SCIENTIFIC INC.
BRAIN SCIENTIFIC INC. (BRSF): 9 pipeline candidates · ~2 mo cash runway · 23 clinical trials. Updated within the last hour.
BioSniper Score
4-factor signal · derived from public data
2.2 months
D/E 1.72 · 0% dilution
Lead: Approved
9 candidates
N/A
N/A
A transparent, data-derived signal for BRAIN SCIENTIFIC INC.across cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.
Key Financials
Market Cap
$745
Cash
$748K
Quarterly Burn
$1.2M
Runway
2.2 mo
Revenue
$5K
Cash Runway vs Catalysts
Tracked catalysts land within the current projected cash runway.
Pipeline (9 candidates)
| Drug | Phase |
|---|---|
| braintemp neonate system | — |
| neurocap | Approved |
| neuroeeg | Approved |
| neurohub | Preclinical |
| non-vitamin k oral anticoagulant | — |
| oral paliperidone er | Phase 3 |
| oral risperidone | Phase 3 |
| quetiapine | Phase 3 |
| single antiplatelet therapy or no therapy | — |
Frequently asked questions
How many drug candidates are in BRAIN SCIENTIFIC INC.'s pipeline?
BRAIN SCIENTIFIC INC. (BRSF) has 9 pipeline candidates tracked by BioSniper across SEC filings and clinical trial registrations.
What is BRAIN SCIENTIFIC INC.'s cash runway?
Based on its most recent reported cash balance and quarterly burn rate, BRAIN SCIENTIFIC INC. has approximately 2.2 months of cash runway.
What is BRAIN SCIENTIFIC INC.'s market capitalization?
BRAIN SCIENTIFIC INC.'s market capitalization is approximately $745.
Who is the CEO of BRAIN SCIENTIFIC INC.?
Mr. Hassan Kotob is the chief executive officer of BRAIN SCIENTIFIC INC. (BRSF).
Get the full picture on BRAIN SCIENTIFIC INC.
Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.